Factors associated with adherence to remote patient monitoring
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Introduction
•

•

•

•

About 80% of head and neck
cancer (HNC) patients who receive
radiation treatment (RT) experience
mucositis and other symptoms that
impact eating and drinking. As
such, dehydration risk is increased
during RT, causing hospitalization
in one-third of patients.
The CYCORE system used mobile
and sensor technology to remotely
monitor blood pressure/pulse,
weight, and patient-reported
outcomes in HNC patients daily
during RT (Figure 1).
Clinicians reviewed patientgenerated data daily via a web
portal (Figure 1) to evaluate
dehydration risk and intervened
when medically necessary.
The ability to detect dehydration
risk through remote patient
monitoring (RPM) depends on
patients’ adherence to daily
monitoring requirements.
Adherence may be influenced by
factors such as symptom burden,
engagement with technology, and
perceived utility of daily monitoring.

Participants and Methods
•
•
•
•

Eligibility: HNC diagnosis; receiving bilateral RT; age > 18 years;
English proficient; Zubrod score < 2; no prior dysphagia or RT.
Patients were recruited at start of RT and randomized to CYCORE
+ usual care, or usual care only.
Measures: MD Anderson Symptom Inventory-HN (MDASI-HN);
Patient Activation Measure (PAM); Perceived Device Usefulness.
Statistical methods included longitudinal analysis to compare the
relationship between daily monitoring adherence and symptom
burden (MDASI-HN), patient engagement (PAM), and perceived
utility (device usefulness) in patients randomized to CYCORE.

Results

Results (cont.)
•
•

•

•

Table 1. Demographic characteristics of patients randomized to CYCORE

Conclusions
•

Table 2. MD Anderson Symptom Inventory-Head & Neck

•

Study Aim
Evaluate the association between HNC
patients’ adherence to daily remote
monitoring and symptom burden,
patient engagement, and perceived
utility of monitoring.

Most participants were male,
White, and married (Table 1).
As symptom severity and
interference with daily living
increased, adherence to remote
monitoring decreased (Table 2).
No significant correlation between
Patient Activation Measure
(PAM) and adherence to remote
monitoring was found (Table 3).
No significant association between
overall perceived usefulness of
CYCORE devices and adherence
to remote monitoring was found,
except for a single item indicating
perceived feeling of security (Table
4).

•
Table 3. Patient Activation Measure

Figure 1. CYCORE provided a platform for mobile and sensor data
collection and storage. User interface displayed daily blood
pressure/pulse and weight, and indications for orthostatic
hypotension.

•

p = 0.242

Table 4. Percent Perceived Device Usefulness

Although a benefit of RPM may be
early detection and mitigation of
symptoms during cancer treatment,
higher symptom burden may
interfere with RPM adherence.
This finding may have implications
for clinical implementation of RPM.
PAM scores indicated that patients
may demonstrate higher levels of
patient activation in general, which
may account for the non-significant
correlations.
Better adherence to RPM may be
attributed to patients’ perceiving a
sense of security from daily
monitoring and may suggest a
potentially important value that
patients gain from RPM.
Understanding factors that impact
patient adherence to RPM may
help improve acceptability and
clinical utility of RPM in oncology.
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